Biotech startup Ligon Discovery attracts $1M in VC funds

By Brendan Lynch

Video Gallery

MHT's Galen Moore: Honoring innovation in New England

Companies born in the recession

MHT's Julie Donnelly: Life science startups finding investments

OncoPep licenses cancer vaccine, moves to add $500K to Series A [February 13, 2012]

Spin Transfer whips up $36M in first round [February 13, 2012]

VBI Vaccines pulls in $2.2M debt round [February 13, 2012]

Yottaa adds CDN to its website booster offerings [February 13, 2012]

Cambridge startup Ligon Discovery Inc. reports it has landed $1 million in funding from incTank Ventures.

Ligon is a biotechnology company using proprietary small molecule microarray technology to identify drug candidates. The startup said it plans to use the funding to screen more than 100 proteins to determine their viability as drugs.

Ligon was founded by Patrick Kleyn, Angela Koehler and Benjamin Ebert, with technology licensed from Harvard University and MIT’s Broad Institute.

Christian Bailey, general partner at Cambridge-based incTank, will join Ligon’s board of directors.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.